A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Deucravacitinib D3 | CAS 1609393-89-6 - Request Quote

Picture of Deucravacitinib D3

Deucravacitinib D3

SZ CAT No:SZ-D143D01
CAS No
1609393-89-6
Mol.F.
C6H2D3Cl2N3O
Mol.Wt.
209.0
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Deucravacitinib D3 is chemically 4,6-Dichloro-N-(methyl-d3)pyridazine-3-carboxamide. Deucravacitinib D3 is supplied with detailed characterization data compliant with regulatory guideline. Deucravacitinib D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Deucravacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1609393-89-6

Purchase 1609393-89-6

Order 1609393-89-6

Enquire 1609393-89-6

price of 1609393-89-6

1609393-89-6 Supplier

1609393-89-6 Manufacturer

1609393-89-6 Exporter

buy high quality Deucravacitinib D3

Purchase Deucravacitinib D3

Deucravacitinib D3 suppliers

Deucravacitinib D3 manufacturers

Deucravacitinib D3 price

Order Deucravacitinib D3

Enquire Deucravacitinib D3

Deucravacitinib D3 cost

Deucravacitinib D3 Supplier

Deucravacitinib D3 Distributor

Deucravacitinib D3 for Method Validation

Deucravacitinib Reference Standard

Deucravacitinib D3 for ANDA Filing

Deucravacitinib D3 for Forced Degradation Studies

Deucravacitinib D3 Identification Standards

Deucravacitinib D3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,